39 results on '"Scott, Véronique"'
Search Results
2. Supplementary Tables S1-S11 from Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer
3. Supplementary Figures S1-S24 from Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer
4. Data from Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer
5. Abstract 6570: Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer
6. Data from Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy
7. Supplementary Table 1 from Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy
8. Supplementary Methods from Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy
9. Supplementary Table 2 from Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy
10. Supplementary Figure Legend from Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy
11. Supplementary Figures 1 - 7 from Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy
12. Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer
13. Comparative Genomic Profiling of Second Breast Cancers following First Ipsilateral Hormone Receptor–Positive Breast Cancers
14. Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer
15. Chk1 as a new therapeutic target in triple-negative breast cancer
16. Retinoic Acid Receptor Alpha Amplifications and Retinoic Acid Sensitivity in Breast Cancers
17. Whole exome sequencing of rare aggressive breast cancer histologies
18. Gene copy number variations in breast cancer of Sub-Saharan African women
19. Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis
20. Comments on the use of a single or multiple probeset approach for microarray-based analyses of routine molecular markers in breast cancer
21. Ribosomal RNA 2′O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer
22. Ribosomal RNA 2′ O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer
23. Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis
24. Expression of erythropoietin and its receptor in neuroblastomas
25. Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects
26. Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patients
27. Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis
28. Abstract 2524: A new mTOR-independent effect of rapamycin: Transcriptional regulation of TRIB3
29. Abstract 435: Is PYGM dysregulation involved in breast cancer cell metabolism
30. Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy
31. Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patients
32. Portrait of Ependymoma Recurrence in Children: Biomarkers of Tumor Progression Identified by Dual-Color Microarray-Based Gene Expression Analysis
33. Contagious apoptosis facilitated by the HIV-1 envelope: fusion-induced cell-to-cell transmission of a lethal signal
34. A Non-AUG-Defined Alternative Open Reading Frame of the Intestinal Carboxyl Esterase mRNA Generates an Epitope Recognized by Renal Cell Carcinoma-Reactive Tumor-Infiltrating Lymphocytes In Situ
35. A hsp70-2 Mutation Recognized by CTL on a Human Renal Cell Carcinoma
36. In situ T-cell responses in a primary regressive melanoma and subsequent metastases: A comparative analysis
37. <TOGGLE>In situ</TOGGLE> T-cell responses in a primary regressive melanoma and subsequent metastases: A comparative analysis
38. Erratum: Ribosomal RNA 2' O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer.
39. COX2/PTGS2 Expression Is Predictive of Response to Neoadjuvant Celecoxib in HER2 -negative Breast Cancer Patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.